Molecular characterisation of KIR2DS2*005, a fusion gene associated with a shortened KIR haplotype

Genes and Immunity

Volumn 12, Issue 7, 2011, Pages 544-551

  Ordoez D ^a   Gomez Lozano N ^a   Rosales, L ^a   Vilches, C ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

allelic polymorphism; copy number variation; killer cell immunoglobulin like receptors; major histocompatibility complex; natural killer cells; recombination

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2;

ALLELE; ARTICLE; BASE PAIRING; CONTROLLED STUDY; CROSSING OVER; GENE EXPRESSION; GENE FUSION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; HYBRID GENE; INTRON; LINKAGE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLELES; BASE SEQUENCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION; GENE FUSION; GENE ORDER; HAPLOTYPES; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; RECEPTORS, KIR; SEQUENCE ALIGNMENT;

EID: 80054875119     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.35     Document Type: Article

References (20)

1. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004; 16: 626-633. (Pubitemid 39165891)
2. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, Sheer D et al. Plasticity in the organization and sequences of human KIR/ ILT gene families. Proc Natl Acad Sci USA 2000; 97: 4778-4783. (Pubitemid 30238634)
3. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 2003; 62: 79-86. (Pubitemid 36918680)
4. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217-251. (Pubitemid 34293425)
5. Abi-Rached L,Moesta AK, RajalingamR, Guethlein LA, Parham P. Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. PLoS Genet 2010; 6: e1001192.
6. Pyo CW, Guethlein LA, Vu Q,Wang R, Abi-Rached L, Norman PJ et al. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One 2010; 5: e15115.
7. Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham P. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J Immunol 2010; 185: 4233-4237.
8. Robinson J, Mistry K, McWilliam H, Lopez R, Marsh SG. IPD-the Immuno Polymorphism Database. Nucleic Acids Res 2009; 38: D863-D869.
9. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001; 57: 22-31. (Pubitemid 32151072)
10. VandenBussche CJ, Mulrooney TJ, Frazier WR, Dakshanamurthy S, Hurley CK. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun 2009; 10: 162-173.
11. Ordoñez D, Meenagh A, Gomez-Lozano N, Castaño J, Middleton D, Vilches C. Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes. Genes Immun 2008; 9: 431-437.
12. Gourraud PA, Meenagh A, Cambon-Thomsen A, Middleton D. Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics 2010; 62: 729-740.
13. Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009; 113: 3119-3129.
14. Gomez-Lozano N, de Pablo R, Puente S, Vilches C. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur J Immunol 2003; 33: 639-644. (Pubitemid 36367667)
15. Gomez-Lozano N, Estefana E, Williams F, Halfpenny I, Middleton D, Sols R et al. The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. Eur J Immunol 2005; 35: 16-24. (Pubitemid 40123847)
16. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 2005; 201: 1319-1332. (Pubitemid 40629074)
17. Vilches C, Pando MJ, Rajalingam R, Gardiner CM, Parham P. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes. Tissue Antigens 2000; 56: 453-456.
18. Della Chiesa M, Romeo E, Falco M, Balsamo M, Augugliaro R, Moretta L et al. Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol 2008; 38: 2284-2289.
19. Vilches C, Castaño J, Gomez-Lozano N, Estefan?a E. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 2007; 70: 415-422. (Pubitemid 47537402)
20. Gomez-Lozano N, Trompeter HI, de Pablo R, Estefan?a E, Uhrberg M, Vilches C. Epigenetic silencing of potentially functional KIR2DL5 alleles: implications for the acquisition of KIR repertoires by NK cells. Eur J Immunol 2007; 37: 1954-1965. (Pubitemid 47065131)